Five Years and Counting: Clinical Experience on MRIdian

MRIdian Symposium and Site Visit

13 - 14 November 2019,  Rome, Italy

Five Years and Counting: Clinical Experience on MRIdian

MRIdian Symposium and Site Visit

13 - 14 November 2019
Rome, Italy

ViewRay is dedicated to supporting the MRIdian system in the international markets, and ensuring we continue to foster our relationship with our early adopters who are paving the way for patients to benefit from this groundbreaking technology. 

To help strengthen the MRIdian user community, we will host the 2019 EMEA ViewRay Users' Meeting on 13 November 2019 to share best practices, foster networking and advance the science of MR guided RT. The day following this event, ViewRay will host a Symposium for clinicians considering the purchase of the MRIdian system. The day will feature presentations by many current MRIdian users and is designed to help educate clinicians on the strategic, economic, clinical and technical aspects of the MRIdian. After the Symposium, attendees will be given a tour of Gemelli ART to see MRIdian in action.

For more information or to be invited to these events, please email Heather Schmidt at hschmidt@viewray.com.

 

Wednesday, 13 November 2019

8:00 - 18:30

MRIdian Users' Meeting

The Westin Excelsior, Rome

Via Vittorio Veneto, 125

Rome, Italy 


19:00

Dinner 

Ristorante Andrea

Via Sardinia, 28

Rome, Italy 

 

 


 

Thursday, 14 November 2019

9:00 - 17:00

Symposium and Tour

A. Gemelli University Hospital

Largo Agostino Gemelli, 8

Rome, Italy 

 

*Transportation will be provided between the Westin Excelsior and Gemelli ART

 

 

Join Us for Dinner with Other MRIdian Users


 

 

You can't beat the cancer you can't see. 

With added clarity provided by MRIdian real-time imaging, physicians are better equipped to account for any motion caused by respiration or other bodily processes and personalize each treatment. 


Learn more about MRI-Guided ROAR™

First pioneered by ViewRay in 2012, MRI-Guided ROAR™ (Real-time On-table Adaptive Radiotherapy) represents a new paradigm in cancer treatment. It provides clinicians with the ability to improve targeting precision and accuracy to deliver higher, and potentially more effective, radiation doses.

Watch the video below:


 


We look forward to seeing you in Rome!

www.viewray.com
© VIEWRAY TECHNOLOGIES, INC. ("VIEWRAY"). ALL RIGHTS RESERVED. INTENDED FOR HEALTHCARE PROFESSIONALS ONLY. | Privacy Policy